Insider Transactions Reported by 14 Insiders of Summit Therapeutics Inc.

Symbol
SMMT on Nasdaq
Location
Miami, FL

Insiders trading volume in the past year

Summit Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert W. Duggan Co-Chief Executive Officer, Director, 10%+ Owner $11,488,215,999 +$6,484,739 +0.06% 02 Jan 2026
Mahkam Zanganeh Co-Chief Executive Officer, Director, 10%+ Owner $11,378,164,341 +$6,484,739 +0.06% 02 Jan 2026
Yu Xia Director $600,800,855 +$9,999,983 +1.7% 02 Jan 2026
Manmeet Soni COO and CFO, Director $59,051,320 21 Oct 2025
Bhaskar Anand Chief Accounting Officer $3,682,233 08 Jan 2026
Ankur Dhingra Chief Financial Officer $1,331,093 26 Mar 2024
Urte Gayko Director $528,000 25 Apr 2022
Mostafa Ronaghi Director $321,300 02 Jan 2026
Kenneth A. Clark Director $155,892 02 Jan 2026
Ujwala Mahatme Director $115,599 02 Jan 2024
Jeff Huber Director $86,592 02 Jan 2026
Robert F. Booth Director $62,896 02 Jan 2026
Alessandra Cesano Director $28,198 02 Jan 2026
Jeffrey R. Maranian VP Corporate Controller $19,800 15 Dec 2021

Recent Insider Transactions by Companies or Individuals for Summit Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.